FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2038995854> ?p ?o ?g. }

• W2038995854 endingPage "847" @default.
• W2038995854 startingPage "840" @default.
• W2038995854 abstract "Bisphosphonates are widely used to treat skeletal complications of malignancy. These drugs accumulate in bone where they inhibit osteoclastic bone resorption and reduce the local release of factors that stimulate tumor growth. The mechanism of action of bisphosphonates is dependent on chemical structure: Nonnitrogen-containing compounds (e.g., etidronate, clodronate) are metabolized into cytotoxic analogues of ATP, whereas the more potent nitrogen-containing compounds (N-BPs; e.g., pamidronate, ibandronate, zoledronic acid) inhibit protein prenylation, thus affecting cell function and survival. Because protein prenylation is required by all cells, not just osteoclasts, the possibility arises that N-BPs could also affect the viability of tumor cells.Several groups have investigated the in vitro effects of bisphosphonates, either alone or in combination with other antineoplastic agents, on the viability and metastatic properties of many tumor cell types. Similarly, the effect of bisphosphonate treatment on osteolysis and tumor burden has been studied in a variety of animal tumor models.In vitro, submicromolar concentrations of N-BPs inhibited tumor cell adhesion and reduced invasion through extracellular matrix. At higher concentrations, antiproliferative and proapoptotic effects have been reported. In animal models of bone metastases, bisphosphonate treatment markedly reduced osteolytic lesions. There is also evidence of a reduction in tumor burden in bone and occasionally in other organs. Survival may be prolonged, but bisphosphonates do not appear to inhibit the growth of primary soft tissue tumors or orthotopic xenografts.The cell culture data clearly demonstrated that N-BPs exert antitumor properties and interact synergistically with other antineoplastic agents. As bisphosphonates accumulate in bone, they can also exert cytostatic effects on tumor cells in bone metastases, either directly or indirectly via osteoclast inhibition and alterations in the bone microenvironment. Further in vivo research is now required to optimize the dosing regimen of N-BPs to exploit fully their antitumor potential." @default.
• W2038995854 created "2016-06-24" @default.
• W2038995854 creator A5041789762 @default.
• W2038995854 date "2003-01-23" @default.
• W2038995854 modified "2023-10-18" @default.
• W2038995854 title "Antitumor effects of bisphosphonates" @default.
• W2038995854 cites W129503514 @default.
• W2038995854 cites W1900105093 @default.
• W2038995854 cites W1937662086 @default.
• W2038995854 cites W193883077 @default.
• W2038995854 cites W1948558382 @default.
• W2038995854 cites W1964350922 @default.
• W2038995854 cites W1971712306 @default.
• W2038995854 cites W1973405855 @default.
• W2038995854 cites W1977203209 @default.
• W2038995854 cites W1982055377 @default.
• W2038995854 cites W1989014251 @default.
• W2038995854 cites W1994414479 @default.
• W2038995854 cites W1994807600 @default.
• W2038995854 cites W1995181451 @default.
• W2038995854 cites W1995341351 @default.
• W2038995854 cites W1998691432 @default.
• W2038995854 cites W2001735552 @default.
• W2038995854 cites W2006387967 @default.
• W2038995854 cites W2007001439 @default.
• W2038995854 cites W2008316410 @default.
• W2038995854 cites W2011035915 @default.
• W2038995854 cites W2014223559 @default.
• W2038995854 cites W2014375336 @default.
• W2038995854 cites W2020561186 @default.
• W2038995854 cites W2024311349 @default.
• W2038995854 cites W2024479120 @default.
• W2038995854 cites W2028655010 @default.
• W2038995854 cites W2033294313 @default.
• W2038995854 cites W2036608246 @default.
• W2038995854 cites W2040874414 @default.
• W2038995854 cites W2041686004 @default.
• W2038995854 cites W2041868422 @default.
• W2038995854 cites W2044794329 @default.
• W2038995854 cites W2048748629 @default.
• W2038995854 cites W2052659304 @default.
• W2038995854 cites W2058500908 @default.
• W2038995854 cites W2059387208 @default.
• W2038995854 cites W2061088080 @default.
• W2038995854 cites W2063699543 @default.
• W2038995854 cites W2066014756 @default.
• W2038995854 cites W2066639236 @default.
• W2038995854 cites W2073620146 @default.
• W2038995854 cites W2079634278 @default.
• W2038995854 cites W2081461802 @default.
• W2038995854 cites W2092853101 @default.
• W2038995854 cites W2094554330 @default.
• W2038995854 cites W2098097319 @default.
• W2038995854 cites W2112314464 @default.
• W2038995854 cites W2133111205 @default.
• W2038995854 cites W2135723303 @default.
• W2038995854 cites W2144860907 @default.
• W2038995854 cites W2155728216 @default.
• W2038995854 cites W2166725822 @default.
• W2038995854 cites W2326495145 @default.
• W2038995854 cites W2411616733 @default.
• W2038995854 cites W2434959743 @default.
• W2038995854 cites W2473227341 @default.
• W2038995854 cites W2783103906 @default.
• W2038995854 cites W4242024627 @default.
• W2038995854 cites W4244533966 @default.
• W2038995854 cites W60551495 @default.
• W2038995854 cites W80228164 @default.
• W2038995854 doi "https://doi.org/10.1002/cncr.11128" @default.
• W2038995854 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12548584" @default.
• W2038995854 hasPublicationYear "2003" @default.
• W2038995854 type Work @default.
• W2038995854 sameAs 2038995854 @default.
• W2038995854 citedByCount "283" @default.
• W2038995854 countsByYear W20389958542012 @default.
• W2038995854 countsByYear W20389958542013 @default.
• W2038995854 countsByYear W20389958542014 @default.
• W2038995854 countsByYear W20389958542015 @default.
• W2038995854 countsByYear W20389958542016 @default.
• W2038995854 countsByYear W20389958542017 @default.
• W2038995854 countsByYear W20389958542018 @default.
• W2038995854 countsByYear W20389958542019 @default.
• W2038995854 countsByYear W20389958542020 @default.
• W2038995854 countsByYear W20389958542021 @default.
• W2038995854 countsByYear W20389958542022 @default.
• W2038995854 countsByYear W20389958542023 @default.
• W2038995854 crossrefType "journal-article" @default.
• W2038995854 hasAuthorship W2038995854A5041789762 @default.
• W2038995854 hasBestOaLocation W20389958541 @default.
• W2038995854 hasConcept C126322002 @default.
• W2038995854 hasConcept C141071460 @default.
• W2038995854 hasConcept C170493617 @default.
• W2038995854 hasConcept C181199279 @default.
• W2038995854 hasConcept C185592680 @default.
• W2038995854 hasConcept C202751555 @default.
• W2038995854 hasConcept C2776033226 @default.
• W2038995854 hasConcept C2776326535 @default.
• W2038995854 hasConcept C2776541429 @default.

• next